Agnès Arbat

Agnès Arbat has extensive experience in the pharmaceutical and biotechnology industry. Agnès currently serves as the CEO and CMO of Oxolife, a clinical-stage company focused on reproductive efficiency. Agnès is responsible for leading the development of a molecule to enhance female fertility success. Agnès is also a Co-Founder of Oxolife and directs the development of clinical strategies and plans for integrating OXO-001 into standard female infertility therapeutic protocols.

In addition to their role at Oxolife, Agnès has served as a Mentor and Associate Professor at the Universitat Pompeu Fabra, where they specialize in the pharmaceutical and biotechnology industry. Agnès has also been a Mentor at the Universitat Internacional de Catalunya.

Prior to their work at Oxolife and the universities, Agnès worked at Bayer as the Head of General Medicine & Women's Health in the Medical Department. Agnès also held the position of Medical Manager for Women's Health at Bayer. Before joining Bayer, Agnès worked in the Medical Affairs department of Organon, specifically focusing on Women's Health.

Overall, Agnès Arbat's work experience demonstrates their expertise in reproductive health, clinical development, and medical affairs in the pharmaceutical and biotechnology industry.

Agnès Arbat attended the Universitat Autònoma de Barcelona from 1991 to 1998, where they obtained a Medical Degree in Graduate in Medicine and Surgery. Agnès then pursued further education at the Hospital Universitari Vall d'Hebron from 2000 to 2004, specializing in Clinical Pharmacology. In addition, Agnès Arbat attended the Universitat de Barcelona in 2003 and 2004 to obtain a Graduate degree in R&D and Regulatory Affairs (RA) in the Pharmaceutical Industry. Agnès'smost recent educational experience took place in 2021 and 2022 at the IESE Business School, where they pursued the PDG-1 program, although the specific degree was not mentioned.